home · filing · 0001393905-23-000367
8-K
filed November 13, 2023, 6:59 PM ET
ticker STME
CIK 0001493712
leadership
confidence high
sentiment neutral
materiality 0.20
Cell MedX COO resigns, stays as director; audit committee appointed
Stimcell Energetics Inc.
Joao da Costa resigned as COO on Nov 7, 2023; continues as director.
Audit committee formed with Dwayne Yaretz (CEO), George Adams, and Joao da Costa.
Adams and da Costa are independent per NI 52-110; Yaretz is not independent.
All three members are financially literate and qualify as audit committee financial experts.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-11-07
Filed November 13, 2023, 6:59 PM ET
On November 7, 2023, Mr. Joao da Costa resigned as Chief Operating Officer of Cell MedX Corp.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Joao da Costa resigned as Chief Operating Officer at Stimcell Energetics Inc..
Action resigned
Role Chief Operating Officer
Exact text from the filing
On November 7, 2023, Mr. Joao da Costa resigned as Chief Operating Officer of Cell MedX Corp.
View on SEC.gov
Source: SEC EDGAR
accession 0001393905-23-000367
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.